Overweight and grade I obesity in patients with cardiovascular disease: To treat or not to treat?

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 12, 2014, Pages 731-739

  Haberka, Maciej ^a   Stolarz Skrzypek, Katarzyna ^b   Czarnecka, Danuta ^b   Gasior, Zbigniew ^a   Olszanecka Glinianowicz, Magdalena ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Coronary artery disease; Heart failure; Hypertension; Obesity paradox; Overweight

Indexed keywords

BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ESSENTIAL HYPERTENSION; FOLLOW UP; GRADE I OBESITY; HEART FAILURE; HUMAN; OBESITY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; UNDERWEIGHT; WEIGHT REDUCTION; ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMORBIDITY; COMPLICATION; FEMALE; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; OBESITY, MORBID; POLAND; PROGNOSIS; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY, MORBID; POLAND; PROGNOSIS; RISK FACTORS;

EID: 84920000537     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2564     Document Type: Review

References (66)

1. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011; 377: 557-567.
2. WHO Global Database on Body Mass Index. http://apps.who.int/bmi/index. jsp Accessed January 21, 2014.
3. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006; 113: 898-918.
4. Lewis CE, McTigue KM, Burke LE, et al. Mortality, health outcomes, and body mass index in the overweight range: A science advisory from the American Heart Association. Circulation. 2009; 119: 3263-3271.
5. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA. 2013; 309: 71-82.
6. Degoulet P, Legrain M, Reach I, et al. Mortality risk factors in patients treated by chronic hemodialysis: Report of the Diaphane Collaborative Study. Nephron. 1982; 31: 103-110.
7. Ellis SG, Elliott J, Horrigan M, et al. Low-normal or excessive body mass index: Newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol. 1996; 78: 642-646.
8. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies. Lancet. 2006; 368: 666-678.
9. McAuley PA, Blair SN. Obesity paradoxes. J of Sports Sci. 2011; 29: 773-782.
10. Hainer V, Aldhoon-Hainerova I. Obesity Paradox does exist. Diabetes Care. 2013; 36: 276-281.
11. Oreopoulos A, Padwal N, Norris CM, et al. Effects of obesity on short-and long-term mortality post coronary revascularization: A meta-analysis. Obesity. 2008; 16: 442-450.
12. Park DW, Kim YH, Yun SC, et al. Association of body mass index with major cardiovascular events and with mortality after percutaneous coronary intervention. Circ Cardiovasc Interv. 2013; 6: 146-153.
13. Hastie CE, Padmanabhan S, Slack R, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010; 31: 222-226.
14. Coutinho T, Goel K, Corea de Sa D, et al. Central obesity and survival in subjects with coronary artery disease. J Am Coll Cardiol. 2011; 57: 1877-1886.
15. Akin I, Tolg R, Hochadel M, et al. No evidence of "obesity paradox" after treatment with drug eluting stents in a routine clinical practice: Results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry. J Am Coll Cardiol Cardiovasc Interv. 2012; 5: 162-169.
16. Shenkeveld L, Magro M, Oemrawsingh RM, et al. The influence of optimal treatment on the "obesity paradox", body mass index, and long-term mortality in patients treated with percutaneous coronary intervention: A prospective cohort study. BMJ. 2012; 2e000 535.
17. Das SR, Alexander KP, Chen AY, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 54, 149 patients with STsegment elevation myocardial infarction. J Am Coll Cardiol. 2011; 58: 2642-2650.
18. Madala MC, Franklin BA, Chen AY, et al. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008; 52: 979-985.
19. Diercks DB, Roe MT, Mulgund J, et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: Results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association guidelines quality improvement initiative. Am Heart J. 2006; 152: 140-148.
20. Stamler R, Ford CE, Stamler J. Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-up Program. Hypertension. 1991; 17: 553-564.
21. Tuomilehto J. Body mass index and prognosis in elderly hypertensive patients: A report from the European Working Party on High Blood Pressure in the Elderly. Am J Med. 1991; 90: S34-S41.
22. Wassertheil-Smoller S, Fann C, Allman RM, et al. Relation of low body mass to death and stroke in the Systolic Hypertension in the Elderly Program. Arch Intern Med. 2000; 160: 494-500.
23. Uretsky S, Messerli FH, Bangalore S, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007; 120: 863-870.
24. Barrios V, Escobar C, Calderon A. Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMI. Obesity. 2010; 18: 2017-2022.
25. Rywik TM, Koziarek J, Piotrowski W, et al. Trends in heart failure mortality in Poland between 1980 and 2010. Pol Arch Med Wewn. 2013; 123: 664-671.
26. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease. Risk factors, paradox, and impact of weight loss. J Am Coll Cardiol. 2009; 53: 1925-1932.
27. Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: A meta-analysis. Am Heart J. 2008; 156: 13-22.
28. Fonarow GC, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: Analysis of body mass index and inhospital nortality for 108 927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007; 153: 74-81.
29. Zafrir B, Adir Y, Shehadeh W, et al. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox". Respir Med. 2013; 107: 139-146.
30. Zamora E, Lupon J, Antonio M, et al. The obesity paradox in heart failure: Is etiology a key factor? Int J Cardiol. 2013; 166: 601-605.
31. Lavie CJ, Osman AF, Milani RV, et al. Body composition and prognosis in chronic systolic heart failure: The obesity paradox. Am J Cardiol. 2003: 91: 891-894.
32. Clark AL, Chyu J, Horwich TB. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol. 2012; 110: 77-82.
33. Clerico A, Giannoni A, Vittorini S, et al. The paradox of low BNP levels in obesity. Heart Fail Rev. 2012; 17: 81-96.
34. Olszanecka-Glinianowicz M, Chudek J. Obesity-induced hypertension. In: Kasprzak JD, Nowicki W, eds. Arterial hypertension: What's new? Wroclaw, Poland: Cornetis; 2011: 36-49.
35. Trullas JC, Formiga F, Montero M, et al. Impact of weight loss on mortality in chronic heart failure: Findings from the RICA Registry. Int J Cardiol. 2013; 168; 306-311.
36. Melenovsky V, Kotrc M, Borlaug BA, et al. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. J Am Coll Cardiol. 2013; 62: 1660-1670.
37. Aktas MK, Zareba W, Huang DT, et al. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device -A MADIT-CRT Sub-Study. J Card Fail. 2014; 20: 183-189.
38. O'Connor ChM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION Randomized Controlled Trial. JAMA. 2009; 301: 1439-1450.
39. Horwich TB, Broderick S, Chen L, et al. Relation between body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol. 2011; 108: 1754-1759.
40. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2012;33: 1635-1701.
41. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34: 2949-3003.
42. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010; 31: 2501-2555.
43. Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: A meta-analysis. J Clin Epidemiol. 2008; 61: 646-653.
44. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: Meta-regression analysis of prospective studies. Eur Heart J. 2007; 28: 850-856.
45. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008; 32: 959-966.
46. Miazgowski T, Major-Goluch A, Safranow K. Selected adipokines and metabolic profiles in normal-weight women with abdominal obesity. Pol Arch Med Wewn. 2012; 122: 406-412.
47. Fitzgibbons TP, Hardy OT, Lessard D, et al. Body mass index, treatment practices, and mortality in patients with acute heart failure. Coron Artery Dis. 2009; 20: 536-543.
48. McAuley PA, Beavers KM. Contribution of cardiorespiratory fitness to the obesity paradox. Prog Cardiovasc Dis. 2014; 56: 434-440.
49. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012; 14: 803-869.
50. Pergola G, Nardecchia A, Giagulli VA, et al. Obesity and heart failure. Endocr Metab Immune Disord Drug Targets. 2013; 13: 51-57.
51. Chrysant SG, Chrysant GS. New insight into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens. 2013; 7: 85-94.
52. Cybulska B, Klosiewicz-Latoszek L. What does obesity paradox mean in coronary heart disease. Kardiol Pol. 2013; 71: 963-968.
53. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006; 355: 763-778.
54. Kadakia MB, Fox CS, Scirica BM, et al. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: Observations from the MERLIN-TIMI 36 trial. Heart. 2011; 97: 1782-1787.
55. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004; 43: 1439-1444.
56. Johnson J, Romero-Corral A, Somers VK, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil. 2008; 15: 336-340.
57. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J, Zurakowski A. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity. Metabolism. 2004; 53: 1268-1273.
58. Olszanecka-Glinianowicz M, Chudek J, Kocelak P, et al. Body fat changes and activity of tumor necrosis factor a system-A 5-year follow-up study. Metabolism. 2011; 60: 531-536.
59. Olszanecka-Glinianowicz M, Chudek J, Szromek A, Zahorska-Markiewicz B. Changes of systemic microinflammation after weight loss and regain -A five-year follow up study. Endokrynol Pol. 2012; 63: 432-438.
60. Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011; 34: 1481-1486.
61. Gaesser GA, Angadi SS, Sawyer BJ. Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals. Phys Sportsmed. 2011; 39: 87-97.
62. Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: Evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013; 346: E8707.
63. Pereira MA, O'Reilly E, Augustsson K, et al. Dietary fiber and risk of coronary heart disease: A pooled analysis of cohort studies. Arch Intern Med. 2004; 164: 370-376.
64. Swift DL, Johannsen NM, Lavie CJ, et al. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis. 2014; 56: 441-447.
65. Barry VW, Baruth M, Beets MW, et al. Fitness vs fatness on all-cause mortality: A meta-analysis. Prog Cardiovasc Dis. 2014; 56: 382-390.
66. 2008 Physical Activity Guidelines for Americans 2008. http://www. health.gov/paguidelines/pdf/paguide.pdf. Accessed July 1, 2014.